TwinBeech Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,300
Closed -$262K 623
2025
Q4
$262K Buy
+3,300
New +$260K 0.02% 501
2025
Q1
Sell
-1,382,790
Closed -$62.1M 758
2024
Q4
$62.1M Buy
+1,382,790
New +$77.6M 1.06% 19
2023
Q2
Sell
-28,925
Closed -$2.15M 649
2023
Q1
$2.15M Buy
+28,925
New +$2.43M 0.04% 364
2022
Q2
Sell
-176,791
Closed -$17.9M 545
2022
Q1
$17.9M Buy
+176,791
New +$18.6M 0.79% 34
2021
Q3
Sell
-28,288
Closed -$2.36M 618
2021
Q2
$2.36M Buy
+28,288
New +$2.32M 0.29% 114
2021
Q1
Sell
-17,912
Closed -$1.22M 489
2020
Q4
$1.22M Sell
17,912
-3,321
-16% -$216K 0.2% 150
2020
Q3
$1.24M Buy
+21,233
New +$1.32M 0.27% 114
2020
Q2
Sell
-42,124
Closed -$2.5M 386
2020
Q1
$2.5M Buy
+42,124
New +$2.81M 1% 25

Other funds holding CVS

TwinBeech Capital's CVS Position: Q1 2026 in Review

TwinBeech Capital sold out of CVS Health (CVS) in Q1 2026, closing a stake of 3,300 shares — an estimated $262K sold.

TwinBeech Capital first reported a position in CVS in Q1 2020 and held it in 8 quarters. The position peaked at $62.1M in Q4 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • TwinBeech Capital reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • TwinBeech Capital sold 3,300 CVS Health shares in Q1 2026, an estimated $262K.
  • TwinBeech Capital first reported a position in CVS Health in Q1 2020 and held it in 8 quarters.
  • TwinBeech Capital's CVS Health position peaked at $62.1M in Q4 2024.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on TwinBeech Capital's 13F filing for Q1 2026, filed 15 May 2026.